.jpg "Pankajini Mallick, PhD photo")
Principal Scientist, Preclinical Pharmacokinetics | DMPK
Neurocrine Biosciences
San Diego, California
Dr. Pankajini Mallick is Ph.D. in Pharmaceutical Sciences from University of Houston in Texas and currently a Principal Scientist at Neurocrine Bioscience in San Diego, where she applies state-of-the-art knowledge in various competencies including Pharmacokinetics (PK), PK/PD, and physiologically based (PBPK) models to predict human exposure of small molecules to guide candidate selection for further development to treat neurological, psychiatric, and endocrine related disorders. Prior to joining Neurocrine Biosciences, Dr. Mallick spent 3 years at ScitoVation (ICSS division of The Hamner Institutes for Health Sciences) in North Carolina, where she focused on development and application of PBPK modeling and In vitro to In vivo Extrapolation (IVIVE) in chemical risk assessment. She has contributed to several successful INDs and CTA filings and possesses a significant track record of publications in leading journals in the area of toxicology, computational modeling, and drug metabolism.
Disclosure information not submitted.
Monday, October 17, 2022
1:30 PM – 2:30 PM ET